Why this is the strongest evidence in the whole field
Of all the practices that sit near tantra, present-moment mindful attention to bodily sensation has by far the strongest clinical evidence base for sexual difficulty. This matters because it is also, mechanistically, almost exactly what foundational tantric and sensate practice trains: non-judgemental awareness of what the body is actually feeling, with the performance goal explicitly removed. The research lead here is Lori Brotto's Sexual Health Lab at the University of British Columbia, whose sustained programme of randomised controlled trials has effectively built the evidence base for mindfulness in sexual medicine from the ground up.
If you want to know whether the 'be present in your body' instruction at the heart of tantric practice has any scientific teeth, this is the literature that answers it — and the answer is largely yes, with important and specific limits that deserve equal clarity. The evidence is replicated across multiple studies, has been tested online as well as in clinic, and includes active-control comparisons rather than just pre-post designs. In a field that is chronically under-evidenced, this is unusually strong.
What the mindfulness literature does not do is prove that everything sold as 'tantric practice' works. It proves specific mechanisms — attentional training, present-moment body focus, de-spectatoring — that some tantric practices use. The tantra label adds no additional evidence; the mechanism evidence stands on its own, and honest teaching should acknowledge that directly.
What the SIAD trials found
The most developed evidence is for women's sexual interest and arousal difficulties (SIAD). Brotto and colleagues' early pilot work established feasibility and preliminary signals. Their foundational randomised trial, the DESIRE study published in the Journal of Consulting and Clinical Psychology in 2021, randomised 148 women with SIAD to either mindfulness-based cognitive therapy (MBCT) or a supportive sex education and therapy comparison. Eight weekly group sessions. Outcomes measured sexual desire, arousal, distress, relationship satisfaction, and global impressions of change, at baseline, post-treatment, and at 6- and 12-month follow-up.
Both treatments produced strong to very strong effects. Mindfulness was equivalent to or superior on rumination, distress, and women's own sense of global change, with the effects maintained at twelve months. This is not a marginal finding — the effect sizes are clinically meaningful, the active-control design rules out non-specific factors, and the twelve-month follow-up is more rigorous than most psychological treatment research ever achieves.
A subsequent mediator analysis examined what was driving the change. Self-reported interoceptive awareness, self-compassion, and mindfulness itself emerged as mediators — consistent with the mechanism the treatment proposes. When the treatment works, it works through the hypothesised pathway. That mechanistic coherence strengthens the interpretation considerably.
The online trial that changes the picture
The single most consequential study for anyone considering an at-home programme is the eSense randomised controlled trial, published in Behaviour Research and Therapy in 2025. Brotto and colleagues randomised 129 women with SIAD to eSense-CBT (n=43), eSense-MBT (mindfulness-based therapy; n=43), or waitlist (n=43). Both interventions consisted of eight online modules with a recommended twelve-week completion window, supported by remote contact with non-expert 'navigators.'
The results: compared to waitlist, both active arms produced significant improvements in desire and arousal at post-treatment — effect sizes of d > 0.90 for the primary sexual outcomes, d < −0.62 for sexual distress. These are large effects by psychological treatment standards. The gains were maintained at six-month follow-up. There was little difference in outcomes between the mindfulness and CBT versions, which is itself informative: the active ingredient may be the structure and attention-training rather than the specific cognitive or mindfulness frame.
The delivery format is the critical practical point. This is randomised-trial evidence specifically for online, self-directed delivery — not an assumption that clinic-room results generalise to apps and websites. That distinction is rare in sexual health research, and it is the empirical foundation under the entire concept of a structured digital programme for women's sexual difficulties. It does not mean any online product works; it means this specific format, delivered with this level of structure and support, has been tested and works.
Mindfulness for sexual pain
The evidence extends beyond desire and arousal into sexual pain. In the COMFORT trial published in the Journal of Sexual Medicine in 2019, Brotto and colleagues randomised approximately 130 women with a clinical diagnosis of provoked vestibulodynia (PVD) to either mindfulness-based cognitive therapy or cognitive behavioural therapy, delivered in eight weekly group sessions at a hospital clinic. Both treatments produced improvements in pain during intercourse, with mindfulness performing comparably to CBT on pain and equivalent or superior on several psychological endpoints.
This is clinically important for two reasons. First, it gives women with a genuinely distressing, physically-grounded condition a second well-evidenced psychological option alongside the established CBT. Second, the comparability finding is an important honesty marker: mindfulness is as effective as CBT, not magically better, and neither treatment replaces the physical and procedural treatments that vestibulodynia and vaginismus also require. It sits alongside medical and physiotherapy care, not instead of it.
A longer-term follow-up of the COMFORT participants, published subsequently, found that improvements were maintained and that mindfulness continued to predict better outcomes over time. This durability is consistent with the finding in the DESIRE trial — these are not transient effects that decay quickly after treatment ends.
What mindfulness is actually doing
Across the trials, a consistent mechanism emerges. Sexual difficulty — particularly desire, arousal, and pain difficulties — is frequently maintained by 'spectatoring': mentally stepping outside the experience to monitor, judge, and grade your own performance. Barry McCarthy coined the term in clinical sex therapy contexts, and research has confirmed it as a consistent predictor of sexual difficulty. Mindfulness training directly targets spectatoring: it rebuilds the capacity to notice and stay with bodily sensation without immediately jumping to evaluation.
Rumination and off-task distraction are the other main maintenance mechanisms. People with low desire often find that during intimacy their minds wander to unrelated concerns, worries, or to-do lists. People with pain concerns anticipate pain, which activates bracing and autonomic responses that can create the very experience they are anticipating. Mindfulness training — the deliberate, repeated practice of returning attention to the body and to the present moment — disrupts both of these loops.
This is why the same core skill helps across desire, arousal, and pain presentations. It is not condition-specific; it is attention-specific. And it is why the foundational tantric practices — which train exactly this capacity through breath, body scanning, and non-goal-oriented touch — are pointing at something real, even though they were never tested under that name. The mechanism is what the evidence establishes; the delivery vehicle can vary.
Where the evidence stops — the honest caveats
Three honest limits. First, the strongest evidence is in women. The male-side mindfulness literature for sexual difficulty exists but is significantly thinner: single-team studies on mindfulness for premature ejaculation show directional benefit, and there are smaller studies on mindfulness for erectile difficulty with performance anxiety, but none have the sample sizes, replication, or methodological rigour of the Brotto programme. Overstating the male evidence is a common error; we will not make it here.
Second, mindfulness-based therapy is well-evidenced as a treatment but is not a universal solvent. For desire discrepancy between partners — where one person wants sex substantially more than the other — the field explicitly acknowledges there is no established evidence-based treatment. Mindfulness has not changed that status. It may improve the individual's capacity for arousal and presence, but desire discrepancy is fundamentally a relational and compatibility problem that individual treatment typically cannot solve alone.
Third, 'mindfulness-based therapy' in these trials is a structured, clinician-designed, multi-session protocol — not the same as using a meditation app before sex or doing a ten-minute body scan. The evidence is for the programme: eight weeks of structured sessions, specific content, facilitated processing. A casual mindfulness practice overlaps with the skill but is not the same delivery format as the tested intervention. When choosing a programme, the gap between 'mindfulness app' and 'structured evidence-based programme' matters.
How to use this evidence
The practical takeaway is specific. If you are a woman with low desire, difficulty with arousal, or provoked vestibulodynia, a structured mindfulness-based programme is one of the best-evidenced psychological options available to you — and the online delivery research means a well-built at-home version is a legitimate first-line choice, not a second-best substitute. Ideally with clinician involvement or oversight; the eSense model used non-expert navigators as a minimal support layer, which suggests that full clinician delivery is not always necessary but some structured support helps.
If your difficulty has a clear physical or medical driver — hormonal changes, pelvic floor dysfunction, a skin or tissue condition, medication effects — mindfulness is an adjunct after or alongside the medical workup, not a replacement for it. Sexual difficulties that have a physical component respond to both the physical treatment and the psychological one; the evidence supports using both.
If a programme markets itself as 'tantric' but the active ingredient is structured mindful body-attention, you are effectively buying the well-evidenced mechanism under a different name. That is not necessarily dishonest — it depends on whether the programme is built on the actual protocol or just using mindfulness as a marketing word. The evidence does not care about the label; it cares about whether the structure and practice actually match what has been tested.